Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.330
-0.040 (-1.69%)
Jun 3, 2026, 12:07 PM EDT - Market open
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
61
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,856,984
Market Cap
168.29M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 0 | - | 60 | 1 |
| Dec 31, 2024 | 61 | 9 | 17.31% | 61 | 0 |
| Dec 31, 2023 | 52 | 12 | 30.00% | 51 | 1 |
| Dec 31, 2022 | 40 | 23 | 135.29% | 39 | 1 |
| Dec 31, 2021 | 17 | 10 | 142.86% | 14 | 3 |
| Mar 31, 2021 | 7 | - | - | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| MediWound | 121 |
| Tenaya Therapeutics | 70 |
| Precision BioSciences | 66 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| Jyong Biotech | 27 |
| Spero Therapeutics | 25 |
ABOS News
- 20 days ago - Acumen Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Acumen Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - Acumen Pharmaceuticals Earnings release: Q1 2026 - Filings
- 22 days ago - Acumen Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 22 days ago - Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 22 days ago - Acumen Pharmaceuticals Slides: Corporate presentation - Filings
- 26 days ago - Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference - GlobeNewsWire
- 4 weeks ago - Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 - GlobeNewsWire